Similar Stories to Depomed Gets Favorable Nucynta Patent Decision on Bing News

Depomed Inc. said it received a favorable court decision on its patents for its Nucynta painkiller products and expected the ruling would result in market exclusivity through 2025.

Sections:  business   
Topics:  health   
RELATED ARTICLES
    BING NEWS:
    • Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise
      In 2023, FDA granted New Patient Population exclusivity for Nucynta in pediatrics ... changing market conditions for our products; the outcome of any patent infringement or other litigation that may ...
      06/12/2024 - 9:00 pm | View Link
    • More

     

    Welcome to Wopular!

    Welcome to Wopular

    Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

    Senh Duong (Founder)
    Wopular, MWB, RottenTomatoes

    Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

    MoviesWithButter : Our Sister Site

    More News